The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 774-780, October 2008

Serum ferritin and transferrin levels as serologic markers of methylene diphenyl diisocyanate–induced occupational asthma

  • Gyu-Young Hur, MD, PhD

      Affiliations

    • Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, South Korea
  • ,
  • Gil-Soon Choi, MD

      Affiliations

    • Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, South Korea
  • ,
  • Seung-Soo Sheen, MD, PhD

      Affiliations

    • Pulmonary and Critical Care Medicine, Ajou University School of Medicine, Suwon, South Korea
  • ,
  • Hyun-Young Lee, MS

      Affiliations

    • Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, South Korea
  • ,
  • Han-Jung Park, MD

      Affiliations

    • Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, South Korea
  • ,
  • Sung-Jin Choi, MD

      Affiliations

    • Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, South Korea
  • ,
  • Young-Min Ye, MD

      Affiliations

    • Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, South Korea
  • ,
  • Hae-Sim Park, MD, PhD

      Affiliations

    • Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, South Korea
    • Corresponding Author InformationReprint requests: Hae-Sim Park, MD, PhD, Department of Allergy and Rheumatology, Ajou University School of Medicine, San-5, Wonchun-dong, Youngtong-gu, Suwon, 443-721, South Korea.

Received 19 February 2008; received in revised form 28 July 2008; accepted 29 July 2008.

Background

Although methylene diphenyl diisocyanate (MDI) may induce occupational asthma in the workplace, the pathogenic mechanisms are unclear.

Objectives

By using bronchoalveolar lavage fluid, we sought to identify proteins that were differentially expressed between subjects with MDI-induced occupational asthma (MDI-OA) and asymptomatic exposed controls (AECs).

Methods

To find proteins that were differentially expressed between the MDI-OA and AEC groups, 2-dimensional electrophoresis was performed by using bronchoalveolar lavage fluid obtained from subjects after MDI-specific inhalation challenge. The selected protein spots were then identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The clinical relevance of the differentially expressed spots was compared by ELISA using sera from the MDI-OA/eosinophilic bronchitis, AEC, and unexposed healthy control groups. Receiver operating characteristic curves were then plotted, and the sensitivity and specificity were determined.

Results

Twenty-three protein spots were identified that distinguished the subjects with MDI-OA from those in the AEC group. Among them, ferritin expression was downregulated whereas transferrin expression was upregulated in subjects with MDI-OA compared with AEC; these results were validated by ELISA using sera from the MDI-OA/EB and AEC groups. To identify subjects with MDI-OA, the optimal serum cutoff levels were 69.84 ng/mL for ferritin and 2.48 μg/mL for transferrin. When these 2 parameters were combined, the sensitivity was 71.43% and the specificity was 85.71%.

Conclusion

Serum ferritin and transferrin levels are associated with the phenotype of MDI-OA.

Key words: MDI, occupational asthma, ferritin, transferrin, proteome

Abbreviations used: 2-DE, 2-Dimensional electrophoresis, AEC, Asymptomatic exposed control, ANCOVA, Analysis of covariance, ARDS, Acute respiratory distress syndrome, AUC, Area under the curve, BALF, Bronchoalveolar lavage fluid, DBP, Vitamin D–binding protein precursor, EB, Eosinophilic bronchitis, MALDI-TOF/TOF MS, Matrix-assisted laser desorption ionization time-of-flight/time-of-flight mass spectrometry, MDI, Methylene diisocyanate, MDI-EB, Methylene diisocyanate–induced eosinophilic bronchitis, MDI-OA, Methylene diisocyanate–induced occupational asthma, MS, Mass spectrometry, NC, Nonatopic healthy control, ROC, Receiver operating characteristic, TDI, Toluene diisocyanate, TDI-OA, Toluene diisocyanate–induced occupational asthma, WRRS, Work-related lower respiratory symptom

 

 Supported by a grant from the Korean Health 21 R&D Project of the Ministry of Health and Welfare, Republic of Korea (A050571).

 G.-Y. Hur is currently with the Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea.

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01368-7

doi:10.1016/j.jaci.2008.07.034

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 774-780, October 2008